Has Holly Jacobson received payments from drug or device companies?

Yes. Drug and device makers reported $2,801 in general payments to Holly Jacobson across 160 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Holly Jacobson did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Holly Jacobson come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Holly Jacobson

Psychiatric/Mental Health · Moorpark, CANPI 1861073322

Payments from drug & device makers

$2,801in general payments, 2019–2025

Across 160 payments — averaging $17.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$725
Otsuka America Pharmaceutical, Inc.$344
Supernus Pharmaceuticals, Inc.$253
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$233
Lundbeck LLC$221
Takeda Pharmaceuticals U.S.A., Inc.$182
plus $844 from 15 others

What the payments were for

Food & beverage$2,801100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie	59	$725
Otsuka America Pharmaceutical, Inc.	17	$344
Supernus Pharmaceuticals, Inc.	7	$253
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	12	$233
Lundbeck LLC	10	$221
Takeda Pharmaceuticals U.S.A., Inc.	9	$182
Corium, LLC	9	$132
Teva Pharmaceuticals USA, Inc.	6	$119
Alkermes, Inc.	4	$80
Neurocrine Biosciences, Inc.	3	$79
Johnson & Johnson	4	$69
Axsome Therapeutics, Inc.	3	$59
Sunovion Pharmaceuticals Inc.	4	$58
Almatica Pharma LLC	3	$46
Idorsia Pharmaceuticals US Inc	2	$41
Bausch Health US, LLC	2	$37
E.r. Squibb & Sons, L.L.C.	2	$36
Sage Therapeutics, LLC	1	$23
OWP Pharmaceuticals, Inc.	1	$23
Indivior Inc.	1	$22
Tris Pharma Inc	1	$19

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

QELBREE$157
CAPLYTA$108

How this compares

$2,801 in reported general payments places this provider in the 80th percentile of 2,433 psychiatric/mental health providers in California.

See all psychiatric/mental health providers in California →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Lisdexamfetamine Dimesylate	11	$3,040
Quetiapine Fumarate	46	$1,449
Bupropion XlBupropion Hcl	64	$892
Gabapentin	56	$735
Escitalopram Oxalate	54	$535
Duloxetine Hcl	28	$524
Sertraline Hcl	49	$492
Trazodone Hcl	50	$447
Aripiprazole	27	$407
Prazosin Hcl	15	$388
Hydroxyzine Pamoate	23	$329
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine	16	$265
Bupropion Hcl SrBupropion Hcl	20	$228
Temazepam	12	$207
Paroxetine Hcl	24	$148

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

Company	Paid to this provider	Part D cost of their drugs
Almatica Pharma LLCSertraline Hcl	$46	$49249 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 2,433 psychiatric/mental health providers in California.

Other psychiatric/mental health in Moorpark

Carey MartinMillbrae$745K
Liberty MaciasRedlands$288K
Joshua BurgettSacramento$239K
Jovita Ezirim-SalamialofojeLos Angeles$162K
Angie-Kolleen TanThousand Oaks$159K
Thy LamVista$121K
David OhIrvine$72K
Samantha PerkinsAnaheim$49K
Yvette ElpidioOrange$43K
Sarah KoLos Angeles$34K

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →